Guardian Pharmacy (GRDN) SVP Chris Crisafulli Converts 18,931 Shares

What Happened

• Chris Crisafulli, Senior Vice President, Payor and Industry Strategy at Guardian Pharmacy Services (GRDN), reported derivative activity on 2026-09-27. The Form 4 shows 18,931 shares acquired via exercise/conversion (code M) and 18,931 shares disposed the same day. No per‑share or total dollar price is reported on the filing.
• A footnote clarifies these were automatic one‑for‑one conversions of Class B common stock into Class A common stock under the company’s charter, effective September 27, 2026.

Key Details

• Transaction date: 2026-09-27; Form 4 filed: 2026-09-28 (filed promptly the next day).
• Reported amounts: 18,931 shares acquired (conversion/exercise) and 18,931 shares disposed — net change = 0 shares.
• Price: N/A (no cash consideration reported for the conversion/disposition).
• Notable footnotes: F1 — automatic one‑for‑one Class B to Class A conversion; F2 — excludes 21,343 Class A shares subject to a domestic relations order (to be transferred under a divorce settlement).
• Filing timeliness: Timely (filed one day after the reported transaction).

Context

• Transaction code M denotes exercise or conversion of a derivative. Here the filing indicates a charter‑driven conversion of Class B into Class A shares, followed by a same‑day disposition; because no price is reported, this does not show a cash purchase or clear market sale.
• For retail investors: conversions and internal reorganizations can generate Form 4 entries that do not reflect a purchase or sale for investment reasons. The domestic relations order note may affect the Reporting Person’s ultimate beneficial ownership but is separate from this conversion/disposition event.